Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities

Cedric Manlhiot, Leonardo R. Brandão, Zeeshanefatema Somji, Amy L. Chesney, Catherine MacDonald, Rebecca C. Gurofsky, Tarun Sabharwal, Nita Chahal, Brian W. McCrindle

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities'. Together they form a unique fingerprint.

Medicine & Life Sciences